Lv1
10 积分 2024-03-25 加入
Global burden of COPD: risk factors, prevalence, and future trends
12小时前
已完结
Update on Clinical Aspects of Chronic Obstructive Pulmonary Disease
13小时前
已完结
Elevated circulating memory T cells precede immunotherapy toxicities in melanoma
7个月前
已完结
Befotertinib (D-0316) versus icotinib as first-line therapy for patients with EGFR-mutated locally advanced or metastatic non-small-cell lung cancer: a multicentre, open-label, randomised phase 3 study
8个月前
已完结
An updated patent review of small-molecule c-Met kinase inhibitors (2018-present)
9个月前
已完结
Tepotinib plus osimertinib in patients with EGFR-mutated non-small-cell lung cancer with MET amplification following progression on first-line osimertinib (INSIGHT 2): a multicentre, open-label, phase 2 trial
9个月前
已完结
Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial
9个月前
已完结
Genomic alterations driving precancerous to cancerous lesions in esophageal cancer development
9个月前
已完结
ICOS-L as a Potential Therapeutic Target for Cancer Immunotherapy
10个月前
已完结
Pembrolizumab versus ipilimumab for advanced melanoma: final overall survival results of a multicentre, randomised, open-label phase 3 study (KEYNOTE-006)
10个月前
已完结
皖公网安备34019202002308
